Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia

SIMPLE SUMMARY: Acute Myeloid Leukemia is an aggressive disease with poor outcomes. New targeted therapies that can boost the effects of currently used chemotherapy medications without added toxicity are needed. Targeting an overactive kinase, called the protein Kinase CK2 in AML, helps leukemia cel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Klink, Morgann, Rahman, Mohammad Atiqur, Song, Chunhua, Dhanyamraju, Pavan Kumar, Ehudin, Melanie, Ding, Yali, Steffens, Sadie, Bhadauria, Preeti, Iyer, Soumya, Aliaga, Cesar, Desai, Dhimant, Huang, Suming, Claxton, David, Sharma, Arati, Gowda, Chandrika
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7975325/
https://ncbi.nlm.nih.gov/pubmed/33807974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051127
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars